DERM - Journey Medical GAAP EPS of -$0.53 misses by $0.30 revenue of $13M misses by $1.1M May, 14 2024 03:56 AM Journey Medical Corporation 2024-05-14 03:56:41 ET More on Journey Medical Journey Medical announces U.S. FDA acceptance of NDA for its rosacea treatment Seeking Alpha’s Quant Rating on Journey Medical Historical earnings data for Journey Medical For further details see: Journey Medical GAAP EPS of -$0.53 misses by $0.30, revenue of $13M misses by $1.1M